Skip to content
DPIIT recognised District

HOYNOZA TECHNOLOGIES PRIVATE LIMITED

Bengaluru, Karnataka

Sectors as filed: Others

The website is as filed on the register. We have not checked that it resolves.

Six things we look for on every record: DPIIT recognition, a CIN, a website, a description, a logo and a funding signal. Not held here: Funding signal.

What this record amounts to

HOYNOZA TECHNOLOGIES PRIVATE LIMITED is a Startup India record we can place no finer than Bengaluru district, which holds 34,244 records in this snapshot. 178 of those records are filed under Biotechnology, 1% of the district. It carries no funding signal of any class, which is true of 30,570 of the 34,244 records in Bengaluru.

Every figure above is counted from the 2026-08 snapshot and is the same number the page it links to prints.

In their own words

Hoynoza Technologies Pvt Ltd is a leading company at the forefront of healthcare and life sciences, dedicated to delivering innovative solutions, services, and products. With a strong emphasis on research and development, we are committed to driving advancements in thepharmaceutical, biopharmaceutical, diagnostics, and wellness industries. Our relentless pursuit of excellence, cutting-edge technologies, and customer satisfaction make us a trusted partner for clients worldwide.Hoynoza Technologies Pvt Ltd, where innovation and groundbreaking scientific advancements are at the core of our work. We are a leading biotechnology company dedicated to developing novel therapeutic solutions to address unmet medical needs. Our expertise lies in multiple areas, including MAb development, platform technologies, bio-organoids, and bispecific antibody development.One of our key areas of focus is the development of novel monoclonal antibodies (MAbs). MAbs are engineered to target specific disease markers, enabling highly targeted and effective treatmentoptions. Our team utilizes state-of-the-art technologies and a deep understanding of disease mechanisms to develop MAbs with enhanced therapeutic properties. By leveraging our expertise in antibody engineering and optimization, we are at the forefront of MAb development, providinginnovative solutions to combat various diseases. Furthermore, Hoynoza Technologies is proud to pioneer novel platform technologies that enable faster and more efficient drug discovery and development processes. We leverage advanced computational modeling, high-throughput screening techniques, and cutting-edge data analytics toidentify potential drug candidates with high precision. Our platform technologies streamline the drug development pipeline, reducing time and cost while increasing the success rate of bringing innovative therapies to market.In our pursuit of scientific excellence, we are also invested in the development of bio-organoids. These three-dimensional cell culture models mimic the complexity and functionality of human organs, allowing us to study diseases in a more physiologically relevant environment. By utilizing bio-organoids, we gain crucial insights into disease mechanisms and test potential therapeutic interventions, accelerating the discovery and development of transformative treatments.Additionally, our expertise extends to bispecific antibody development. Bispecific antibodies are designed to simultaneously target multiple disease targets, offering unique therapeutic opportunities. Through our advanced engineering approaches, we develop bispecific antibodies withimproved efficacy and reduced side effects, providing innovative treatment options for diseases with complex mechanisms.At Hoynoza Technologies, our commitment to innovation and cutting-edge research drives us to continuously push the boundaries of what is possible in the field of biotechnology. By leveraging our expertise in MAb development, platform technologies, bio-organoids, and bispecific antibodydevelopment, we are poised to revolutionize the landscape of healthcare and make a meaningful impact on patients' lives

Written by the company on its public Startup India profile. Not verified by us.

What the record says

DPIIT recognition number
DIPP148263
CIN
U21001KA2023PTC174057
Registered on Startup India
2023
Self-declared stage
Validation
Industry
Biotechnology
Biotechnology in Bengaluru
178 records
District
Bengaluru
State
Karnataka

Where this is

District

Bengaluru

Karnataka

Startup India records the district. We do not have a street address for this company, and we will not invent one.

No point is drawn, because we do not have one.

Geocode confidence: medium

See all Bengaluru records on the map How we placed this record

The neighbourhood

This record carries no locality line, so the district is the finest ring we can place it in.

What we do not know

We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.

How we built this record Where the data comes from How you may reuse it

Keep looking

One record is one row. Bengaluru has 34,244.

See Bengaluru